Schering Buoyed by FDA Priority Cancer Drug Review
550498
German drug maker Schering AG was  boosted on Thursday as the U.S. Food and Drug Administration  granted its Bonefos treatment "priority review" for preventing  bone tumors in breast cancer patients.
264861
Osteoporosis drug could give the company its next big winner.
205867
German drug maker Schering, recently acquired by pharmaceuticals and chemicals giant Bayer, has said that it was teaming up with British drug giant AstraZeneca to develop a new treatment against breast cancer.
320147
Cancer drug shows exceptional promise as it moves toward FDA review.
181860
Platforms have the potential to develop multiple drugs for a company.
220351
Shares of ViroPharma (VPHM:Nasdaq - news - research) were among the best-performing health and pharmaceutical stocks Monday after Schering-Plough (SGP:NYSE - news - research) said it would pay $10 million to license ViroPharma&#39;s cold drug.
664968
Promising drug test results make this a company to watch.
156434
An experimental cancer drug made by Abbott Laboratories Inc. passed its first round of human testing about six months faster than usual, thanks to a new program that aims to speed drug development.
279186
WASHINGTON The first new cancer drug in ten years that is specifically designed to help children is a step closer to approval. An advisory panel at the Food and Drug Administration is recommending the use
26608
German and Swiss drug makers Schering and Novartis are developing a new anti-cancer drug with annual sales potential of up to two billion euros (2.7 billion dollars), Schering chief Hubertus Erlen said.
105288
WASHINGTON -- The Food and Drug Administration yesterday approved a cancer drug made by pharmaceutical giant Eli Lilly and Co. to treat advanced non-small cell lung cancer in patients who have undergone chemotherapy.
750028
Shares in Schering dropped on Friday  after the German drugmaker said U.S. regulators needed more  information to approve its key Bonefos drug for use in  preventing bone tumors in breast cancer patients.
147168
The approval of a new drug is a long-term opportunity.
80318
A drug company hopes to win federal approval early next month for a novel cervical cancer vaccine that it touts as the next biggest thing since the pap test in fighting the No. 2 cancer in women.
482241
The drugmaker bumps into the FDA as it pushes to do more testing of Entereg.
724324
Inhibitex Inc. stood out from a mixed biotechnology sector Monday, jumping more than 20 percent on news that it will receive a fast-tracked review for a staph-infection treatment.
458929
U.S. health officials said on Friday  they would review whether to take regulatory action over Merck  & Co Inc and Schering-Plough's cholesterol medicine Vytorin  following the drug's failure to work better than a generic drug  in a study of plaque build-up in neck arteries.